USA-based biotech Locus Biosciences is to receive $23.9 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administrat 25 January 2024
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.